Ikarian Capital, LLC Neuronetics, Inc. Call Options Transaction History
Ikarian Capital, LLC
- $714 Million
- Q1 2025
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding STIM
# of Institutions
103Shares Held
18.7MCall Options Held
96.2KPut Options Held
58.4K-
Vanguard Group Inc Valley Forge, PA2.31MShares$9.8 Million0.0% of portfolio
-
Kent Lake Capital LLC Mill Valley, CA1.74MShares$7.39 Million1.44% of portfolio
-
Balyasny Asset Management LLC Chicago, IL1.42MShares$6.02 Million0.01% of portfolio
-
Masters Capital Management LLC Atlanta, GA1MShares$4.25 Million0.19% of portfolio
-
Manatuck Hill Partners, LLC Westport, CT920KShares$3.91 Million1.7% of portfolio
About Neuronetics, Inc.
- Ticker STIM
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 27,022,800
- Market Cap $115M
- Description
- Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...